ATE129013T1 - Steroid 5-alpha-reduktase. - Google Patents

Steroid 5-alpha-reduktase.

Info

Publication number
ATE129013T1
ATE129013T1 AT91909339T AT91909339T ATE129013T1 AT E129013 T1 ATE129013 T1 AT E129013T1 AT 91909339 T AT91909339 T AT 91909339T AT 91909339 T AT91909339 T AT 91909339T AT E129013 T1 ATE129013 T1 AT E129013T1
Authority
AT
Austria
Prior art keywords
preparation
steroid
alpha
disclosed
sequences
Prior art date
Application number
AT91909339T
Other languages
English (en)
Inventor
Stefan Andersson
David W Russell
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE129013T1 publication Critical patent/ATE129013T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/01—Oxidoreductases acting on the CH-CH group of donors (1.3) with NAD+ or NADP+ as acceptor (1.3.1)
    • C12Y103/01022—3-Oxo-5alpha-steroid 4-dehydrogenase (NADP+) (1.3.1.22), i.e. cortisone alpha-reductase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91909339T 1990-04-30 1991-04-25 Steroid 5-alpha-reduktase. ATE129013T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51766190A 1990-04-30 1990-04-30

Publications (1)

Publication Number Publication Date
ATE129013T1 true ATE129013T1 (de) 1995-10-15

Family

ID=24060703

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91909339T ATE129013T1 (de) 1990-04-30 1991-04-25 Steroid 5-alpha-reduktase.

Country Status (8)

Country Link
US (2) US5422262A (de)
EP (1) EP0528906B1 (de)
JP (1) JP3294844B2 (de)
AT (1) ATE129013T1 (de)
AU (1) AU642501B2 (de)
CA (1) CA2079454C (de)
DE (1) DE69113795T2 (de)
WO (1) WO1991017251A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3294844B2 (ja) * 1990-04-30 2002-06-24 ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム ステロイド５α―リダクターゼ
US5576191A (en) * 1994-06-17 1996-11-19 Immunex Corporation Cytokine that binds ST2
US5656613A (en) * 1995-01-04 1997-08-12 Merck & Co., Inc. Treatment of hyperandrogenic conditions
US5834248A (en) * 1995-02-10 1998-11-10 Millennium Pharmaceuticals Inc. Compositions and methods using rchd534, a gene uregulated by shear stress
US20020170077A1 (en) * 1995-02-10 2002-11-14 Millennium Pharmaceuticals, Inc. Compositions and methods for the treatment and diagnosis of cardiovascular disease
US6359194B1 (en) 1995-02-10 2002-03-19 Millennium Pharmaceuticals, Inc. Compositions and methods for the treatment and diagnosis of cardiovascular disease
IT1276662B1 (it) * 1995-04-04 1997-11-03 Uni Degli Studi Camerino Vaccini polinucleotidici
WO1997020930A1 (en) * 1995-12-07 1997-06-12 Baylor College Of Medicine Urogenital sinus derived growth factor nucleotide and amino acid sequences
AU725192B2 (en) 1996-02-16 2000-10-05 Brigham And Women's Hospital Compositions and methods for the treatment and diagnosis of cardiovascular disease
AU2666797A (en) * 1996-04-15 1997-11-07 Dyad Pharmaceutical Corporation Combination therapy for androgenic alopecia with antisense oligonucleotides and minoxidil
US6143950A (en) 1996-04-18 2000-11-07 The Salk Institute For Biological Studies Plant steroid 5α reductase, DET2
ATE301674T1 (de) * 1996-05-15 2005-08-15 Altana Pharma Ag Verfahren zur trennung und bestimmung von hydrophoben proteinen durch dünnschichtchromatographie
WO1999037986A2 (en) 1998-01-23 1999-07-29 University Of Southern California Androgen-metabolic gene mutations and prostate cancer risk
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
EP1280915A1 (de) * 2000-04-13 2003-02-05 Millennium Pharmaceuticals, Inc. Menschliche 5-alpha reductase und deren anwendungen
US6469150B1 (en) * 2000-05-22 2002-10-22 Pharmacopeia, Inc. Cloning and characterization of genes encoding bradykinin B1 receptor homologues from five mammalian species
AU2002241768A1 (en) * 2000-10-30 2002-06-18 Pharmacia Corporation Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
CN100408099C (zh) * 2000-11-09 2008-08-06 阿斯特拉曾尼卡有限公司 含有嵌段共聚物的口服药物组合物
JP2002236307A (ja) * 2001-02-09 2002-08-23 Asahi Optical Co Ltd ズームストロボ装置
WO2006010038A2 (en) * 2004-07-08 2006-01-26 Biosearch Technologies, Inc. Inducible fluorescence assay
US20070036740A1 (en) * 2004-10-06 2007-02-15 Reed Kenneth C Modulation of hair growth
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
FR2903999B1 (fr) * 2006-07-19 2008-09-05 Galderma Res & Dev S N C Snc Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee
EP2398500B1 (de) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Arzneiabgabesystem auf glutathion-basis
WO2010120262A1 (en) * 2009-04-14 2010-10-21 Smith Holdings, Llc Methods and compositions for the treatment of medical conditions involving cellular programming
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
AU2021207019A1 (en) * 2020-01-16 2022-09-01 Jsr Corporation Composition for producing bile acids
CN117630382A (zh) * 2023-11-25 2024-03-01 温州医科大学附属第二医院（温州医科大学附属育英儿童医院） 大鼠睾丸Leydig祖细胞标志蛋白及其筛选方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3294844B2 (ja) * 1990-04-30 2002-06-24 ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム ステロイド５α―リダクターゼ

Also Published As

Publication number Publication date
DE69113795D1 (de) 1995-11-16
CA2079454A1 (en) 1991-10-31
US5679521A (en) 1997-10-21
JPH05507405A (ja) 1993-10-28
DE69113795T2 (de) 1996-03-28
EP0528906A1 (de) 1993-03-03
WO1991017251A1 (en) 1991-11-14
US5422262A (en) 1995-06-06
AU642501B2 (en) 1993-10-21
JP3294844B2 (ja) 2002-06-24
AU7857991A (en) 1991-11-27
CA2079454C (en) 2002-02-26
EP0528906B1 (de) 1995-10-11

Similar Documents

Publication Publication Date Title
DE69113795D1 (de) Steroid 5-alpha-reduktase.
Slominski et al. Conversion of L‐tryptophan to serotonin and melatonin in human melanoma cells
Roeder et al. Multiple forms of DNA-dependent RNA polymerase in eukaryotic organisms
Normington et al. Tissue distribution and kinetic characteristics of rat steroid 5 alpha-reductase isozymes. Evidence for distinct physiological functions.
Morange et al. Altered expression of heat shock proteins in embryonal carcinoma and mouse early embryonic cells
Mortelmans et al. Defective thymine dimer excision by cell-free extracts of xeroderma pigmentosum cells.
Ramanathan et al. Nonrandom nature of in vivo methylation by dimethylnitrosamine and the subsequent removal of methylated products from rat liver chromatin DNA
NO20011505L (no) Alzheimer's sykdom-sekretase
DE69512219D1 (de) Gezielte spaltung von rns mittels gezielter bindung der ribonuklease p und spaltungssequenzen
ATE167680T1 (de) Pteridin-nukleotidderivate als fluoreszierende sonden
CA2184270A1 (en) Method for Suppressing Inhibition of Enzyme-Mediated Reactions by Ionic Detergents
Sawada et al. Evidence for the participation of two sperm proteases, spermosin and acrosin, in fertilization of the ascidian, Halocynthia roretzi: inhibitory effects of leupeptin analogs on enzyme activities and fertilization
Deems et al. The inhibition of phospholipase A2 by manoalide and manoalide analogues
Wohl et al. Comparison of the esterase and human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes.
Dizdaroglu et al. A novel DNA N-glycosylase activity of E. coli T4 endonuclease V that excises 4, 6-diamino-5-formamidopyrimidine from DNA, a UV-radiation-and hydroxyl radical-induced product of adenine
Rodriguez et al. Mapping of peroxyl radical induced damage on genomic DNA
Riendeau et al. Evidence for a fatty acid reductase catalyzing the synthesis of aldehydes for the bacterial bioluminescent reaction. Resolution from luciferase and dependence on fatty acids.
Wang et al. Kinetics of oxidized cytosine repair by endonuclease III of Escherichia coli
Lin et al. Purification and characterization of mouse kidney beta-glucuronidase.
AU2002257284A1 (en) Pna probes, probe sets, methods and kits pertaining to the detection of candida
Breimer A DNA glycosylase for oxidized thymine residues in Drosophilamelanogaster
Katz et al. Estradiol esters can replace 17β-estradiol in the stimulation of DNA and esterase synthesis by MCF-7 cells: a possible role for the estrogen-sensitive MCF-7 cell esterase
Todhunter et al. Modification of rat liver RNA polymerase I after in vivo stimulation by hydrocortisone or methylisobutylxanthine
Van Nest et al. Effects of dexamethasone and 5-bromodeoxyuridine on protein synthesis and secretion during in vitro pancreatic development
US7501273B2 (en) Peptidylarginine deiminase 6

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties